Business Context and Reporting Period
This Form 8-K Current Report was filed by Lifemd, Inc. on September 14, 2022. The filing primarily addresses corporate governance changes, specifically the appointment of a new member to the Board of Directors.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on the appointment of a director and associated compensatory arrangements.
Material Changes
The material change reported is the appointment of Robert Jindal to the Board of Directors on September 14, 2022. Mr. Jindal brings significant experience in healthcare and public service, including prior roles as Governor of Louisiana and Operating Adviser to Ares Private Equity Group.
Compensatory Arrangements and Governance
In connection with his appointment, Mr. Jindal entered into a Director Agreement with the following compensation terms:
- Restricted Stock: A grant of 75,000 restricted shares of common stock.
- 37,500 shares vest immediately.
- 37,500 shares vest on the two-year anniversary of the agreement.
- Stock Options: An option to purchase 37,500 shares of common stock, vesting in four equal tranches on the 90, 180, 270, and 365-day anniversaries of the agreement.
- Cash Compensation: $6,000 per quarter for services as a board member.
- Vesting Acceleration: Unvested awards vest immediately upon termination for reasons other than "Cause" or prior to a "Change in Control."
The filing states there are no reportable related party transactions under Item 404(a) of Regulation S-K.
Investor Verification Checklist
- Verify the full text of the Director Agreement, Restricted Stock Award Agreement, and Non-Qualified Stock Option Agreement filed as Exhibits 10.1, 10.2, and 10.3.
- Review the press release dated September 20, 2022 (Exhibit 99.1) for additional context on the appointment.
- Confirm the impact of the new equity grants on total share count and potential dilution in subsequent filings.
- Note that this filing contains no financial results; refer to the most recent 10-Q or 10-K for financial performance data.